Control of immune responses by immunoregulatory T cells

被引:22
作者
Rudge, Geordie [1 ]
Gleeson, Paul A. [1 ]
van Driel, Ian R. [1 ]
机构
[1] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
regulatory T cells; tumor immunity; immunoregulation;
D O I
10.1007/s00005-006-0045-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Immunoregulatory T cells play a key role in modifying the immune responses to self antigens, tumor antigens, and pathogenic organisms. This review summarizes recent data on naturally occurring CD4(+) regulatory T cells that constitutively express CD25 (CD25(+) T-reg). We examine the markers that can be used to differentiate these cells from effector T cells, what is known about their mode of action in controlling the activity of effector T cells, the antigenic specificity of CD25(+) T-reg, and their ability to survive and to be selected in vivo. We also summarize specific information on the role of CD25(+) T-reg in controlling anti-tumor responses, an area were manipulation of this subset holds particular clinical promise.
引用
收藏
页码:381 / 391
页数:11
相关论文
共 105 条
[1]
CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[2]
CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells [J].
Antony, PA ;
Piccirillo, CA ;
Akpinarli, A ;
Finkelstein, SE ;
Speiss, PJ ;
Surman, DR ;
Palmer, DC ;
Chan, CC ;
Klebanoff, CA ;
Overwijk, WW ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2591-2601
[3]
Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[4]
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[5]
T cell regulation as a side effect of homeostasis and competition [J].
Barthlott, T ;
Kassiotis, G ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :451-460
[6]
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells [J].
Bensinger, SJ ;
Bandeira, A ;
Jordan, MS ;
Caton, AJ ;
Laufer, TM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :427-438
[8]
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[9]
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination [J].
Casares, N ;
Arribillaga, L ;
Sarobe, P ;
Dotor, J ;
de Cerio, ALD ;
Melero, I ;
Prieto, J ;
Borrás-Cuesta, F ;
Lasarte, JJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5931-5939
[10]
Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO